MétaCan
Menu
← Back to cohort
Record W3213778531 · doi:10.1161/circ.144.suppl_1.9885

Abstract 9885: Overestimation of Anticoagulant Benefit in Patients with Atrial Fibrillation and Low Life Expectancy: Evidence from 12 Randomized Trials

2021· article· en· W3213778531 on OpenAlexaff
Sachin J. Shah, Carl van Walraven, Richard Hobbs, Stuart J. Connolly, Daniel E. Singer

Bibliographic record

VenueCirculation · 2021
Typearticle
Languageen
FieldMedicine
TopicAtrial Fibrillation Management and Outcomes
Canadian institutionsMcMaster UniversityUniversity of Ottawa
Fundersnot available
KeywordsMedicineAtrial fibrillationRandomized controlled trialLife expectancyAnticoagulant therapyCardiologyAnticoagulantInternal medicineIntensive care medicinePopulation

Abstract

fetched live from OpenAlex

Introduction: Formative anticoagulant RCTs for stroke prevention in atrial fibrillation (AF) were completed before the advent of competing risk methods. Neglecting the competing risk of death can overestimate treatment benefit. This is noteworthy because many patients with AF are frail with limited life expectancy. We determined the overestimation of anticoagulant benefit as a function of life expectancy. Methods: We used patient-level data from 12 anticoagulant RCTs that compared warfarin vs. aspirin or placebo. We estimated each patient’s life expectancy using CDC life tables modified for age, sex, comorbidities, and trial enrollment year. We predicted cumulative stroke incidence with and without anticoagulants at 3 years using a Cox model treating death as a censoring event (“standard model”) and again using a Fine-Gray model treating death as a competing event (“competing risk model”). For each patient, we plot the absolute and relative standard model overestimation compared to the competing risk model. We describe the relationship between life expectancy and log-transformed benefit overestimation (Figure A, B). Results: For the 9548 patients (35% women, mean age 74yrs), the median life expectancy was 11.4yrs (IQR 8.4, 15.3). The overall estimated reduction in stroke incidence at 3 years was 7.7% using a standard model and 6.3% using a competing risk model. The absolute and relative overestimation of the standard model increased exponentially as life expectancy decreased. For example, with a life expectancy of 3 years, a standard model would overestimate absolute benefit by 2.8% (95%CI 2.7-2.9%) and the relative benefit by 29.4% (95%CI 29.3-29.4%). Conclusions: For patients with low life expectancy, the anticoagulant benefit is substantially overestimated using standard survival methods. While anticoagulants reduce the risk of stroke, decision tools should account for life expectancy when estimating benefits for patients with AF.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.058
metaresearch head score (Gemma)0.134
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesnone
DomainCandidate signal: Methods · Consensus signal: none
Study designCandidate signal: Meta-analysis · Consensus signal: Meta-analysis
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.942
Threshold uncertainty score0.307

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0580.134
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0060.015
Bibliometrics0.0020.003
Science and technology studies0.0000.002
Scholarly communication0.0040.003
Open science0.0020.001
Research integrity0.0040.003
Insufficient payload (model declined to judge)0.0070.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.079
GPT teacher head0.327
Teacher spread0.249 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

Study designMeta-analysis
DomainMethods
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2021
Admission routes1
Has abstractyes

Explore more

Same venueCirculation→Same topicAtrial Fibrillation Management and Outcomes→French-language works237,207→